AI/ML Innovations Inc (AIML.CX)
0.05
0.00 (0.00%)
CAD |
CNSX |
May 24, 16:00
AI/ML Innovations Revenue (Quarterly): 0.1767M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 0.1767M |
| October 31, 2023 | 0.1745M |
| July 31, 2023 | 0.1727M |
| January 31, 2023 | 0.1382M |
| October 31, 2022 | 0.1086M |
| July 31, 2022 | 0.0631M |
| April 30, 2022 | 0.0654M |
| January 31, 2022 | |
| October 31, 2021 | |
| July 31, 2021 | |
| April 30, 2021 | |
| January 31, 2021 | |
| October 31, 2020 | |
| July 31, 2020 | |
| April 30, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 |
| Date | Value |
|---|---|
| July 31, 2017 | |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 | |
| July 31, 2013 | |
| April 30, 2013 | |
| January 31, 2013 | |
| October 31, 2012 | |
| July 31, 2012 | |
| April 30, 2012 | |
| January 31, 2012 | |
| October 31, 2011 | |
| July 31, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0631M
Minimum
Jul 2022
0.1767M
Maximum
Jan 2024
0.1284M
Average
0.1382M
Median
Jan 2023
Revenue (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5146M |
| Total Expenses (Quarterly) | 0.5996M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 3.461M |
| Gross Profit Margin (Quarterly) | 61.47% |
| Profit Margin (Quarterly) | -291.3% |
| Earnings Yield | -75.42% |
| Normalized Earnings Yield | -73.48 |